Second Sight Medical (EYES) IPO Immediately Halted on Opening Surge
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts EYES Hot Sheet
Join SI Premium – FREE
Today's IPO for Second Sight Medical (NASDAQ: EYES) was immediately halted upon opening for trading at $17 versus the IPO price of $9.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple to launch AI features in China in December after regulatory delay - Bloomberg
- Yiren Digital Ltd. (YRD) Halted, News Pending
- Iambic Therapeutics prices IPO at $16 per share on Nasdaq
Create E-mail Alert Related Categories
Hot IPOs, IPOs, Momentum Movers, Trader Talk, Trading HaltsRelated Entities
IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
